We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Egalet

News List

Adare Acquires Egalet’s Parvulet Technology Platform contractpharma
April 18, 2019
Adare Pharmaceuticals has entered into an agreement with Egalet Corporation to acquire global rights of the Parvulet technology platform and its associated intellectual property (IP).
Egalet's 70% price increase shows the buy-and-hike strategy is alive and well fiercepharma
February 24, 2019
Think the entire pharma industry has moved past the old strategy of buying drug rights, jacking up prices and reaping the rewards? Think again.
Egalet Announces Positive Top-Line Results from Egalet-002 Study americanpharmaceuticacreview
November 20, 2017
Egalet announced positive top-line results from a phase 3 study evaluating the safety of Egalet-002, an abuse-deterrent, extended-release oxycodone developed using an application of the Guardian Technology.